Clinical trials
Hypertrophy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 5 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AVAVA, Inc. | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Lindenwood University | 2 |
| Marymount University | 2 |
| Neodyne Biosciences, Inc. | 2 |
| University of Illinois at Urbana-Champaign | 2 |
| Venus Concept | 2 |
| Alexei Wong | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Apyx Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertrophy | 46 |
| Cicatrix | 7 |
| Cardiomyopathy, Hypertrophic | 4 |
| Hypertrophy, Left Ventricular | 4 |
| Cardiomyopathies | 3 |
| Acne Vulgaris | 2 |
| Heart Failure | 2 |
| Surgical Wound | 2 |
| Angina Pectoris | 1 |
| Aortic Valve Stenosis | 1 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.